普米克气雾剂联合孟鲁司特治疗小儿哮喘的临床效果  

Clinical effect of pulmicort aerosol combined with montelukast in treatment of pediatric asthma

作　　者：郭金岗 GUO Jin-gang(Lushi County People's Hospital,Lushi 472200,Henan,China)

机构地区：[1]河南省卢氏县人民医院

出　　处：《中国校医》2019年第10期752-753,771,共3页Chinese Journal of School Doctor

摘　　要：目的研究普米克气雾剂联合孟鲁司特治疗小儿哮喘的临床效果。方法选择在本院接受治疗的120例哮喘患儿作为研究对象,按照入院时间差异分为对照组和研究组,每组各60例,对照组在一般疗法基础上使用普米克气雾剂治疗,研究组在对照组基础上给予患儿孟鲁司特治疗,观察并比较2组疗效。结果研究组治疗总有效率(95.00%)明显优于对照组(83.33%),差异有统计学意义(P<0.05)。结论使用普米克气雾剂联合孟鲁司特治疗小儿哮喘效果优异,有效缓解患儿症状,值得广泛应用。Objective To study the clinical effect of pulmicort aerosol combined with montelukast in the treatment of childhood asthma. Methods A total of 120 children with asthma who received the treatment in a hospital were divided into a control group(n=60) and a trial group(n=60) according to the difference of admission time. The control group was treated with pulmicort aerosol on the basis of general therapy, and the trial group was treated with montelukast on the basis of the control group. Results The therapeutic efficiency of the trial group(95.00%) was significantly higher than that of the control group(83.33%), and the difference was statistically significant(P<0.05). Conclusion Pulmicort aerosol combined with montelukast is effective in the treatment of childhood asthma, and is worthy of extensive application.

关 键 词：抗哮喘药 哮喘 儿童 

分 类 号：R562[医药卫生—呼吸系统]